Yawen Ju

Yawen Ju is a seasoned clinical scientist with extensive experience in clinical development across various therapeutic areas, including immuno-oncology and hematological cancers. Currently serving as the Director Clinical Scientist at Scholar Rock since June 2020, Yawen has led critical data cleaning strategies and clinical data reviews, contributing to successful database lock and early signal detection. Prior roles include Clinical Research Scientist positions at Karyopharm Therapeutics and X4 Pharmaceuticals, where responsibilities encompassed protocol development, clinical data management, and grant application submissions. Additionally, Yawen has experience managing clinical research projects at Massachusetts General Hospital and translational science initiatives at CureMeta. Academically, Yawen holds a Ph.D. in Pathology from the University of Rochester and a B.S. in Pharmacology from China Pharmaceutical University.